Jefferies Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Jefferies Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$2.64M	–	1793
2024 Q4	$2.64M	Hold	20,000	–	–	0.02%	567
2024 Q3	$2.91M	Hold	20,000	–	–	0.02%	466
2024 Q2	$2.75M	Hold	20,000	–	–	0.03%	455
2024 Q1	$2.74M	Sell	20,000 -33,300	-62%	-$4.55M	0.03%	484
2023 Q4	$7.24M	Sell	53,300 -136,900	-72%	-$16.7M	0.05%	305
2023 Q3	$23.3M	Sell	190,200 -81,500	-30%	-$10.4M	0.21%	72
2023 Q2	$34.5M	Sell	271,700 -165,700	-38%	-$21.5M	0.31%	53
2023 Q1	$56.5M	Sell	437,400 -166,000	-28%	-$21.7M	0.46%	38
2022 Q4	$79.2M	Buy	+603,400	New	+$78M	0.55%	25

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Jefferies Financial Group's IBB Position: Q2 2026 in Review

Jefferies Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 0% in Q2 2026, selling an estimated $172 and leaving 302,306 shares worth $57.5M. The position accounts for 0.38% of the portfolio, ranked #48.

Jefferies Financial Group first reported a position in IBB in Q4 2022 and has held it in 13 quarters since. The position peaked at $65.1M in Q3 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Jefferies Financial Group held 302,306 shares of iShares Biotechnology ETF worth $57.5M as of Q2 2026.
Jefferies Financial Group sold 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
iShares Biotechnology ETF made up 0.38% of Jefferies Financial Group's portfolio in Q2 2026, its #48 holding.
Jefferies Financial Group first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 13 quarters since.
Jefferies Financial Group's iShares Biotechnology ETF position peaked at $65.1M in Q3 2025.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.